Nielk
Senior Member
- Messages
- 6,970
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
Recently on January 12, 2015, the Company issued a report entitled "Low Natural Killer (NK) Activity Observed Across the Chronic Fatigue Syndrome (CFS) Disease Spectrum" that a biomarker natural killer cell cytotoxicity (NKCC), when low, was associated with more symptom severity and debilitation. This report has now been submitted as a scientific paper for peer-review and publication. The report includes a summary of 6 publications totaling over 150 CFS patients which indicates a relationship between increased severity of CFS and low NK cell activity. In 15 subjects with CFS studied by the Company, Ampligen(R) treatment of peripheral blood mononuclear cells in vitro increased the mean NK activity over 100%. Clinical testing is presently underway to determine whether or not NK augmentation by Ampligen(R), to the extent it may occur in vivo, is associated with decreased CFS disease severity and, specifically, increased physical performance.
And here's a new blog calling for advocacy action in relation to Ampligen. It could probably do with a new thread.
Call to Action: Congressional Hearing on Ampligen
Onward Through the Fog (blog)
From the FDA Action Team
March 5, 2015
http://cfstreatment.blogspot.co.uk/2015/03/call-to-action-congressional-hearing-on.html
And here's a new blog calling for advocacy action in relation to Ampligen. It could probably do with a new thread.
Call to Action: Congressional Hearing on Ampligen
Onward Through the Fog (blog)
From the FDA Action Team
March 5, 2015
http://cfstreatment.blogspot.co.uk/2015/03/call-to-action-congressional-hearing-on.html